medigraphic.com
SPANISH

Atención Familiar

ISSN 1405-8871 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 1

<< Back Next >>

Aten Fam 2023; 30 (1)

Tools for Assessing Patients’ Knowledge of Their Anticoagulation Therapy

Puentes-Mojica AM, Duarte-Osorio A, Vivas-Prieto JM
Full text How to cite this article

Language: Spanish
References: 30
Page: 68-72
PDF size: 164.22 Kb.


Key words:

Health Education, Knowledge, Patients, Anticoagulation.

ABSTRACT

Oral anticoagulants, which are widely used in patients with cardiovascular diseases and thromboembolic disorders, among other indications, are high-risk drugs that require adequate control; therefore, it is important for patients to know and understand how they work, in order to achieve safe and effective use, as well as adequate adherence. Evidence has shown that assessing and increasing patients’ knowledge of their anticoagulation therapy leads to better clinical outcomes. In the present study, a search was carried out for developed instruments that assess patients’ knowledge of their anticoagulation therapy and a narrative review of the tools found. There are currently developed and validated five tools in different languages used in patients receiving both, vitamin K antagonists, and direct oral anticoagulants. However, in Spanish, there is still no validated tool that can be used in Spanish-speaking countries.


REFERENCES

  1. Franco Moreno AI, Martín Díaz RM, García NavarroMJ. Direct oral anticoagulants: an update.Med Clin (Barc). 2018;181:198-206.

  2. Di Minno A, Frigerio B, Spadarella G, Ravani A,Sansaro D, Amato M, et al. Old and new oral anticoagulants:food, herbal medicines and drug interactions.Blood Rev. 2017;31:193-203.

  3. Barnes GD, Lucas E, Alexander GC, GoldbergerZD. National trends in ambulatory oral anticoagulantuse. Am J Med. 2015;128(12):1300-1305.

  4. Laverde LP, Gómez SE, Montenegro AC, LinerosA, Wills B, Buitrago AF. Experiencia de unaclínica de anticoagulación. Rev Colomb Cardiol.2015;22(5):224-30.

  5. Ho KH, Van Hove M, Leng G. Trends in anticoagulantprescribing: a review of local policiesin English primary care. BMC Health Serv Res.2020;20:279.

  6. Yu Z, Yu L, Shan C. Trends of ambulatory oralanticoagulant prescription in five major citiesof China, 2012-2017. BMC Health Serv Res.2020;20(1):209.

  7. Machado-Alba JE, García-Betancur S, Villegas-Cardona F, Medina-Morales DA. Patrones deprescripción de los nuevos anticoagulantes orales ysus costos económicos en Colombia. Rev ColombCardiol. 2016;23(4):277-85.

  8. Chen A, Stecker E, Warden BA. Direct oral anticoagulantuse: a practical guide to common clinicalchallenges. J Am Heart Assoc. 2020;9(13):17559.

  9. Lin J, Sklar GE, Oh VM Sen, Li SC. Factorsaffecting therapeutic compliance: a review fromthe patient’s perspective. Ther Clin Risk Manag.2008;4:269-86.

  10. Baker JW, Pierce KL, Ryals CA. INR goal attainmentand oral anticoagulation knowledge of patientsenrolled in an anticoagulation clinic in aveteran’s affairs medical center. J Manag CarePharm. 2011;17(2):133-42.

  11. Cabellos-García AC, Martínez-Sabater A, Castro-Sánchez E, Kangasniemi M, Juárez-Vela R, Gea-Caballero V. Relation between health literacy,self-care and adherence to treatment with oral anticoagulantsin adults: a narrative systematic review.BMC Public Health. 2018;18(1):1157.

  12. Davis NJ, Billett HH, Cohen HW, Arnsten JH.Impact of adherence, knowledge, and quality oflife on anticoagulation control. Ann Pharmacother.2005;39:632-6.

  13. de Souza TF, Colet CF, Heineck I. Knowledgeand information levels and adherence to oral anticoagulanttherapy with warfarin in patients attendingprimary health care services. J Vasc Bras.2018;17(2):109-16.

  14. Winans ARMF, Rudd KM, Triller D. Assessinganticoagulation knowledge in patients new towarfarin therapy. Ann Pharmacother. 2010;44(7-8):1152-7.

  15. Rolls CA, Obamiro KO, Chalmers L, BereznickiLRE. The relationship between knowledge,health literacy, and adherence among patientstaking oral anticoagulants for stroke thromboprophylaxisin atrial fibrillation. Cardiovasc Ther.2017;35(6):e12304.

  16. Rahmani P, Guzman CL, Blostein MD, Tabah A,Muladzanov A, Kahn SR. Patients’ Knowledge OfAnticoagulation and Its Association With ClinicalCharacteristics, INR Control and Warfarin-RelatedAdverse Events. Blood. 2013;122(21):1738.

  17. Mavri A, Ostasevski Fernandez N, Kramaric A,Kosmelj K. New educational approach for patientson warfarin improves knowledge and therapycontrol. Wien Klin Wochenschr. 2015;127(11-12):472-6.

  18. Briggs AL, Jackson TR, Bruce S, Shapiro NL. Thedevelopment and performance validation of a toolto assess patient anticoagulation knowledge. ResSoc Adm Pharm. 2005;1(1):40-59.

  19. Zeolla MM, Brodeur MR, Dominelli A, HainesST, Allie ND. Development and validation of aninstrument to determine patient knowledge: theoral anticoagulation knowledge test. Ann Pharmacother.

  20. 2006;40(4):633-8.20. Praxedes MF da S, de Abreu MHNG, Paiva SM,Mambrini JV de M, Marcolino MS, Martins MAP.Assessment of psychometric properties of the Brazilianversion of the oral anticoagulation knowledgetest. Health Qual Life Outcomes. 2016;14(1).

  21. Türker M, Sancar M, Demirtunç R, Uçar N, UzmanO, Ay P, et al. Validation of a knowledge testin turkish patients on warfarin therapy at an ambulatoryanticoagulation clinic. Turkish J PharmSci. 2021;18(4):445-51.

  22. Mahmoud Ali Matalqah L, Mahmoud MatalqahL, Radaideh K, Azhar Syed Sulaiman S, AzmiHassali M, Ali Sk Abdul Kader M, et al. An instrumentto measure anticoagulation knowledgeamong Malaysian community: a translation andvalidation study of the Oral AnticoagulationKnowledge (OAK) Test. Asian J Biomed PharmSci. 2013;3(20):30-3730.

  23. Garcia FSES, Cunha DCPT da, Manzato R de O,Bolela F, Barbetta PA, Dantas RS. Instrument forAssessing Knowledge of Oral Anticoagulant Therapy:Construction and Validation. J Nurs Meas.2018;26(1):53-71.

  24. Obamiro KO, Chalmers L, Bereznicki LRE. Developmentand validation of an oral anticoagulationknowledge tool (AKT). PLoS One. 2016;11(6).

  25. Magon A, Arrigoni C, Roveda T, Grimoldi P, DellafioreF, Moia M, et al. Anticoagulation KnowledgeTool (AKT): further evidence of validity in theItalian population. PLoS One. 2018;13(8).

  26. Song T, Xin X, Cui P, Li X. Reliability and validityof the Chinese version of the AnticoagulationKnowledge Tool in patients with atrial fibrillation.Chinese J Pract Nurs. 2021;37(16):1218-22.

  27. Metaxas C, Albert V, Stahl M, Hersberger KE,Arnet I. Development and validation of a questionnaireto self-assess patient knowledge of directoral anticoagulants (KODOA-test). Drug HealthcPatient Saf. 2018;10:69-77.

  28. Organización Mundial de la Salud. Guía de labuena prescripción. [Internet]. [Citado 2022 Jul03]. Disponible en: https://www.paho.org/hq/dmdocuments/2012/Guia-de-la-buena-prescripcion-OMS.pdf

  29. Cegala DJ, Marinelli T, Post D. The effects of patientcommunication skills training on compliance.Arch Fam Med. 2000;9(1):57-64.

  30. Mafruhah OR, Huang YM, Shiyanbola OO, ShenGL, Lin HW. Ideal instruments used to measurehealth literacy related to medication use: a systematicreview. Res Social Adm Pharm. 2021;17:1663-72.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Aten Fam. 2023;30